GET A QUOTE

Undercarboxylated Osteocalcin (ucOC): The Bone-Derived Metabolic Regulator

Molecular Structure and Formation

Undercarboxylated Osteocalcin (ucOC) a bioactive version of osteocalcin protein produced by osteoblasts during bone formation lacks γ-carboxylation, on glutamic acid residues unlike its fully carboxylated form which undergoes this modification in the presence of vitamin K; this carboxylation level significantly impacts the proteins biological functions. As a hormone molecule, with a molecular structure that allows it to spread through the bloodstream and interact with various body tissues effectively.

Physiological Functions and Metabolic Regulation

Recent studies have shown that ucOC plays a role, in body metabolism and questions the conventional perception of bones solely as structural elements with key roles in various physiological functions such, as:

Glucose Homeostasis: Stimulation of pancreatic β-cell proliferation, Enhancement of insulin secretion, Improvement of insulin sensitivity in peripheral tissues

Energy Metabolism: Regulation of fat mass, Modulation of energy expenditure, Enhancement of mitochondrial function

Muscle Function: Promotion of muscle glucose uptake, Support of muscle strength and exercise capacity, Regulation of muscle protein synthesis

Clinical Significance and Disease Associations

Research has demonstrated significant associations between ucOC levels and various metabolic disorders:

  • Type 2 Diabetes: Lower ucOC levels correlate with increased diabetes risk
  • Obesity: Reduced ucOC circulation is observed in obese individuals
  • Cardiovascular Disease: Altered ucOC levels may predict cardiovascular events
  • Sarcopenia: Decreased ucOC is associated with age-related muscle loss

Regulation and Therapeutic Potential

The regulation of ucOC involves complex mechanisms influenced by various factors:

Environmental Factors: Exercise intensity and duration, Dietary composition, Vitamin K status

Hormonal Influences: Insulin signalling, Sympathetic nervous system activity, Glucocorticoid levels

The therapeutic potential of ucOC is currently being explored through several approaches:

  • Development of ucOC mimetics
  • Strategies to increase endogenous ucOC production
  • Combination therapies targeting ucOC-related pathways

Future Research Directions

Researchers are currently concentrating their efforts, in areas:

  1. Explaining the entirety of the signalling pathways for ucOC
  2. Exploring treatment options, within the ucOC system
  3. Creating methods of measurement, for use, in settings
  4. Exploring the impacts of ucOC, on types of tissues

Suitable ELISA Kits

Online Enquiry Form

"*" indicates required fields

Please check mark information required:

TESTIMONIALS arrow icon

Your secretory IgA ELISA gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA assay performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA assay's from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford